Alere Inc., the medical-testing supplier under federal scrutiny, received a notice of default from a group of bondholders after the company delayed filing its 2015 financial statement, according to people with knowledge of the matter.
Alere, which agreed in February to be bought by Abbott Laboratories for about $5.8 billion, hasn’t disclosed a default notice through regulatory filings. Some of the company’s senior lenders were told, over a private reporting system, of a March 21 default notice, the people said.
